Pharmafile Logo

Global Value Dossier

- PMLiVE

Novartis and Genentech’s Xolair shown to significantly reduce allergic reactions to food

Food-related anaphylaxis results in 30,000 emergency room visits in the US each year

- PMLiVE

Janssen’s Carvykti recommended by CHMP for earlier multiple myeloma treatment

The blood cancer affects approximately 160,000 people worldwide

- PMLiVE

Researchers develop screening tool to investigate mechanisms behind multiple diseases

The technique will assess genetic changes in cells behind cancer, autoimmunity and neurodegeneration

- PMLiVE

Landmark project boosts sex and gender equity in UK medical research

Major funders are committing to only approving research projects that treat men and women fairly

Photo of Jon in Cuttsy+Cuttsy branded shapes

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Cuttsy + Cuttsy

- PMLiVE

FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar

Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease

Biogen Idec building

Biogen’s Qalsody recommended by CHMP to treat rare form of ALS

Mutations in the SOD1 gene are responsible for approximately 2% of all ALS cases

- PMLiVE

AstraZeneca’s Tagrisso shows promise as lung cancer maintenance therapy

Up to 85% of lung cancer patients are diagnosed with non-small cell lung cancer

- PMLiVE

Cambridge study reveals potential biomarker and target for long COVID treatments

The pro-inflammatory molecule, IFN-Y, persisted until symptoms improved in patients

- PMLiVE

Besins Healthcare appoints Irina Spirieva as general manager for UK and Ireland

Spirieva joins the company from Organon, a Merck & Co company

- PMLiVE

Rare, But Out There: The art of reaching rare disease patients through understanding human experience

Director Helena Wright talks about the importance of understanding the beliefs, emotional drivers and cultural factors that underpin the experience of living with a rare disease, as we mark Rare...

Havas Life London

- PMLiVE

Alexion launches ‘colourUp4RARE challenge’ to mark Rare Disease Day 2024

The campaign is aimed at raising awareness of how to improve quality of life for patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links